TY - JOUR
T1 - Transfection of v-rasHDNA into MCF-7 human breast cancer cells bypasses dependence on estrogen for tumorigenicity
AU - Kasid, Attan
AU - Lippman, Marc E.
AU - Papageorge, Alex G.
AU - Lowy, Douglas R.
AU - Gelmann, Edward P.
PY - 1985
Y1 - 1985
N2 - The natural history of estrogen-responsive breast cancers often involves a phenotypic change to an estrogen-unresponsive, more aggressive tumor. The human breast cancer cell line, MCF-7, which requires estradiol for tumor formation in vivo and shows growth stimulation in response to estradiol in vitro, is a model for hormone-responsive tumors. The v-rasH onc gene was transfected into MCF-7 cells. The cloned MCF-7ras transfectants, which expressed the v-rasH messenger RNA and v-rasH p21 protein (21,000 daltons), were characterized. In contrast to the parental cell line, MCF-7 ras cells no longer responded to exogenous estrogen in culture and their growth was minimally inhibited by exogenous antiestrogens. When tested in the nude mouse, the MCF-7ras cells were fully tumorigenic in the absence of estrogen supplementation. Thus, cells acquiring an activated one gene can bypass the hormonal regulatory signals that trigger the neoplastic growth of a human breast cancer cell line.
AB - The natural history of estrogen-responsive breast cancers often involves a phenotypic change to an estrogen-unresponsive, more aggressive tumor. The human breast cancer cell line, MCF-7, which requires estradiol for tumor formation in vivo and shows growth stimulation in response to estradiol in vitro, is a model for hormone-responsive tumors. The v-rasH onc gene was transfected into MCF-7 cells. The cloned MCF-7ras transfectants, which expressed the v-rasH messenger RNA and v-rasH p21 protein (21,000 daltons), were characterized. In contrast to the parental cell line, MCF-7 ras cells no longer responded to exogenous estrogen in culture and their growth was minimally inhibited by exogenous antiestrogens. When tested in the nude mouse, the MCF-7ras cells were fully tumorigenic in the absence of estrogen supplementation. Thus, cells acquiring an activated one gene can bypass the hormonal regulatory signals that trigger the neoplastic growth of a human breast cancer cell line.
UR - http://www.scopus.com/inward/record.url?scp=0021893220&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0021893220&partnerID=8YFLogxK
U2 - 10.1126/science.4039465
DO - 10.1126/science.4039465
M3 - Article
C2 - 4039465
AN - SCOPUS:0021893220
SN - 0036-8075
VL - 228
SP - 725
EP - 728
JO - Science
JF - Science
IS - 4700
ER -